Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Kingdee Healthcare Raises $14.5 Million for Guangzhou Mobile Health App (in: Deals & Financings)
  Hunan Zhaotai Forms New Zealand JV for Cancer Drug Development (in: Deals & Financings)
  TaiGen Sells 9% of China JV to HEC ChangJiang for $20 Million (in: Deals & Financings)
  Week in Review: Two Major China CROs Move Toward China Public Listings (in: Deals & Financings)
  WuXi AppTec Plans China IPO (in: Deals & Financings)
  ShangPharma Plans to Merge CRO/CMO Operations with Public Entity (in: Deals & Financings)
  C-Bridge Capital and Tasly Invest $150 Million in Two China Biopharmas (in: Deals & Financings)
  Sihuan Pharma Acquires Ambest Pharma China for $160 Million (in: Deals & Financings)
  Haoeyou Raises $40 Million for its China-US Mobile Health App (in: Deals & Financings)
  HitGen to Provide Merck with Drug Leads in New Collaboration (in: Deals & Financings)